Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.
Thalmensi J, Pliquet E, Liard C, Escande M, Bestetti T, Julithe M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Loustau M, Caumartin J, Lachgar A, Huet T, Wain-Hobson S, Langlade-Demoyen P.
Thalmensi J, et al.
Oncoimmunology. 2015 Nov 5;5(3):e1083670. doi: 10.1080/2162402X.2015.1083670. eCollection 2016 Mar.
Oncoimmunology. 2015.
PMID: 27141336
Free PMC article.